The success of both compounds, using different combinations of the same three receptor targets, has validated the multi-agonist approach and opened the door for even more combinations
Average weight loss in trials was around 16% less than the injections, but a real option for people who want to avoid needles altogether
Trial data describe a characterized study drug manufactured to pharmaceutical standards
Interestingly, while antagonism of YIL781 and TAK-779 did not interfere with this effect, the administration of AMD3100, a CXCR4 antagonist, markedly reduced the LC3 II-to-LC3 I ratio in DOX-treated muscle co-administered with GHRP-6, suggesting that CXCR4 signaling plays a crucial role in mediating autophagic responses [2]
George, UT team for immediate assistance
2 Universidad Autnoma del Estado de Mxico